Establishing clinical pharmacist telehealth services during the COVID-19 pandemic
© American Society of Health-System Pharmacists 2020. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
PURPOSE: After community transmission of the novel virus that causes coronavirus disease 2019 (COVID-19) was detected in the State of Washington in February 2020, innovative measures, such as telehealth appointments, were needed to safely continue to provide optimal pharmaceutical care for patients with chronic conditions and cancer.
SUMMARY: Prior to the COVID-19 pandemic, federal regulations limited the scope of telehealth pharmacist services. However, enactment of the Coronavirus Preparedness and Response Supplemental Appropriations Act, followed by guidance by the Centers for Medicare and Medicaid Services and the Department of Health and Human Services, allowed currently credentialed providers (including pharmacists) to continue to provide patient care services via telehealth with fewer restrictions. Our health system has numerous credentialed pharmacists across multiple ambulatory care clinics. In this article, we highlight our process of expediting the implementation of telehealth services. This process included obtaining authorization for the credentialed pharmacists to provide telehealth services, completion of training modules, implementation of new technology platforms, development of new workflows, and utilization of resources for providers and patients to facilitate successful completion of telehealth visits. We also highlight the consent and documentation components crucially important to the telehealth visit and share some of our successes, as well as identified limitations, in providing pharmacist services via telehealth.
CONCLUSION: In the setting of the COVID-19 pandemic, our institution was able to swiftly implement clinical pharmacist telehealth services for many patients, offering a safe and effective way to continue providing a high level of care. This article discusses our experience with and potential limitations of telehealth to assist other pharmacists seeking to implement and/or expand their telehealth services.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
|---|---|
| Enthalten in: |
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists - 77(2020), 17 vom: 20. Aug., Seite 1403-1408 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Segal, Eve M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ambulatory care |
|---|
| Anmerkungen: |
Date Completed 27.07.2021 Date Revised 27.07.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/ajhp/zxaa184 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328249211 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328249211 | ||
| 003 | DE-627 | ||
| 005 | 20231225202546.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ajhp/zxaa184 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1094.xml |
| 035 | |a (DE-627)NLM328249211 | ||
| 035 | |a (NLM)34279578 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Segal, Eve M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Establishing clinical pharmacist telehealth services during the COVID-19 pandemic |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.07.2021 | ||
| 500 | |a Date Revised 27.07.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © American Society of Health-System Pharmacists 2020. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a PURPOSE: After community transmission of the novel virus that causes coronavirus disease 2019 (COVID-19) was detected in the State of Washington in February 2020, innovative measures, such as telehealth appointments, were needed to safely continue to provide optimal pharmaceutical care for patients with chronic conditions and cancer | ||
| 520 | |a SUMMARY: Prior to the COVID-19 pandemic, federal regulations limited the scope of telehealth pharmacist services. However, enactment of the Coronavirus Preparedness and Response Supplemental Appropriations Act, followed by guidance by the Centers for Medicare and Medicaid Services and the Department of Health and Human Services, allowed currently credentialed providers (including pharmacists) to continue to provide patient care services via telehealth with fewer restrictions. Our health system has numerous credentialed pharmacists across multiple ambulatory care clinics. In this article, we highlight our process of expediting the implementation of telehealth services. This process included obtaining authorization for the credentialed pharmacists to provide telehealth services, completion of training modules, implementation of new technology platforms, development of new workflows, and utilization of resources for providers and patients to facilitate successful completion of telehealth visits. We also highlight the consent and documentation components crucially important to the telehealth visit and share some of our successes, as well as identified limitations, in providing pharmacist services via telehealth | ||
| 520 | |a CONCLUSION: In the setting of the COVID-19 pandemic, our institution was able to swiftly implement clinical pharmacist telehealth services for many patients, offering a safe and effective way to continue providing a high level of care. This article discusses our experience with and potential limitations of telehealth to assist other pharmacists seeking to implement and/or expand their telehealth services | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a ambulatory care | |
| 650 | 4 | |a care access | |
| 650 | 4 | |a pharmacy services | |
| 650 | 4 | |a telehealth | |
| 650 | 4 | |a telemedicine | |
| 700 | 1 | |a Alwan, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Pitney, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Taketa, Cathy |e verfasserin |4 aut | |
| 700 | 1 | |a Indorf, Amy |e verfasserin |4 aut | |
| 700 | 1 | |a Held, Lauren |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Kathyrn S |e verfasserin |4 aut | |
| 700 | 1 | |a Son, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Chi, Mary |e verfasserin |4 aut | |
| 700 | 1 | |a Diamantides, Erica |e verfasserin |4 aut | |
| 700 | 1 | |a Gosser, Rena |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists |d 1995 |g 77(2020), 17 vom: 20. Aug., Seite 1403-1408 |w (DE-627)NLM075145952 |x 1535-2900 |7 nnns |
| 773 | 1 | 8 | |g volume:77 |g year:2020 |g number:17 |g day:20 |g month:08 |g pages:1403-1408 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ajhp/zxaa184 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 77 |j 2020 |e 17 |b 20 |c 08 |h 1403-1408 | ||